PridCor Therapeutics, LLC — Form D/A
PridCor Therapeutics, LLC of TUSCALOOSA, AL, a company, filed a Form D amendment with the SEC on 2026-07-06. The offering totals $6.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2026-07-06
- Form: D/A
- Accession: 0002074593-26-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Remaining: $6.0M
- Minimum investment: $20K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-583403
Issuer
- Name: PridCor Therapeutics, LLC
- CIK: 0002074593
- Entity type: Limited Liability Company
- Jurisdiction: ALABAMA
- Incorporated: 2025
- Address: 1837 COMMONS NORTH DRIVE, TUSCALOOSA, AL, 35406
- Phone: 2053660696
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| William L Pridgen | Executive Officer | Tuscaloosa, AL |
| William L Pridgen | Promoter | Tuscaloosa, AL |
| William L Pridgen | Related Person | Tuscaloosa, AL |
| Brian L Corday | Executive Officer | Johns Creek, GA |
| Brian L Corday | Promoter | Johns Creek, GA |
| Brian Corday | Related Person | Johns Creek, GA |
Other filings by this issuer (3)
More